v3.26.3
Income Taxes (Tables)
9 Months Ended
Sep. 30, 2026
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Expense (Benefit)
The following table summarizes the Company’s U.S. federal and state corporate-level income tax expense/(benefit), including related U.S. federal excise tax expense/(benefit), for the following periods:

For the Three Months Ended September 30,For the Nine Months Ended September 30,
2026202520262025
U.S. federal and state corporate-level income tax expense/(benefit)
$3,216 $3,092 $6,375 $9,124 
U.S. federal excise tax expense
1,797 1,750 4,557 4,750 
the following table, which presents the net tax expense/(benefit) recognized by the Company’s taxable subsidiaries for the following periods:
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2026202520262025
Federal and state income tax expense/(benefit) for taxable subsidiaries
$1,419 $1,342 $1,818 $4,374 
Schedule of Deferred Tax Liabilities
The table below presents the net deferred tax liabilities of the Company’s taxable subsidiaries, which are predominantly related to GAAP-to-tax outside basis differences in the taxable subsidiaries’ investments in certain partnership interests, for the following periods:

As of September 30, 2026As of December 31, 2025
Net Deferred Tax Liabilities/Assets$(42,771)$(41,271)